SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-009739
Filing Date
2020-03-10
Accepted
2020-03-10 16:11:17
Documents
3
Period of Report
2020-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prnb-8k_20200310.htm 8-K 32124
2 EX-99.1 prnb-ex991_45.htm EX-99.1 108145
3 GRAPHIC gsbnxa4xdmn3000001.jpg GRAPHIC 4729
  Complete submission text file 0001564590-20-009739.txt   148058
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 20701630
SIC: 2834 Pharmaceutical Preparations